Please login to the form below
drug labels
This page shows the latest drug labels news and features for those working in and with pharma, biotech and healthcare.
Janssen develops digital tools to help automate clinical trials
The programme offers smart packaging, in the form of electronic drug labels, that aim to augment existing booklets but can also be supplemented with other patient-specific data.
Latest news
-
Pharma lobbying in the US
After a trial, Caronia was convicted under specific sections of the Federal Drug and Cosmetic Act (FDCA). ... The argument that in today's day and age with the rise of social media and sophisticated platforms that make data overwhelmingly easy to access
-
FDA insists on GnRH agonists risk warning
The FDA has issued a notification to manufacturers of a class of prostate cancer drug stating that new safety information must be added to labels. ... cancer, informing them that they must add new safety information to the Warnings and Precautions
-
US drug labels lacking
Drug labels in the US often are not explicit about the severity of side effects and the true efficacy of the product, according to NEJM report. ... Medicines labels in the US often do not carry information showing the severity of side effects or details
-
Under 25s at risk
People aged 25 years old and younger who take antidepressants are at much greater risk of suicide than older adults, research from the US Food and Drug Administration (FDA) has revealed. ... The findings support previous studies and the FDA's age-related
-
Hidden blockbuster?
medication, reading of labels, following of drug regimes, and finding out more information, impossible.
More from news
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
Does safety sell medicines?
Is pharmacovigilance unnecessary policing or a strategic asset for pharma companies?
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- New study identifies drugs that are safe to use in COVID-19 treatment
- Keytruda doubles five-year survival rate in NSCLC
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Switzerland: a life sciences hub
- Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
- Responding to dynamic shifts in value communications
- OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
- Doing what we can and having fun doing it: our fundraising month
- Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...
Quick links
Infographics
